The downgrade from Overweight to Equal-Weight by a major analyst like Morgan Stanley suggests a neutral outlook on CDW's stock, implying that the stock may perform in line with the market expectations. The price target of $216 provides a reference point for investors but does not suggest significant upside, hence the neutral score.